Study on multimodal radioomics used to evaluate placental dysplasia disorders

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300077930

Enrollment

Unknown

Registered

2023-11-24

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placental dysplasia disorders

Interventions

Gold Standard:Intraoperative findings and pathological results

Index test:Multimodal magnetic resonance imaging

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women diagnosed with placental dysplasia and normal pregnant women

Exclusion criteria

Exclusion criteria: 1) Other complications of pregnancy: intrahepatic cholestasis of pregnancy, diabetes during pregnancy, immune system diseases during pregnancy, etc. 2) Pregnant women who are unable to undergo regular prenatal examinations at our hospital

Design outcomes

Primary

Measure	Time frame
Sensitivity;Specificity;Receiver operating characteristic curve;Multimodal magnetic resonance imaging;	—

Countries

China

Contacts

Public ContactQiong Luo

Women’s Hospital School of Medicine Zhejiang University

luoq@zju.edu.cn13958023267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026